AMANTA vs GKSL: Stock Comparison

AMANTA vs GUJARAT KIDNEY N SUP SP LUpdated 16 Jun 26, 4:08 PM ISTNSE & company filings

GUJARAT KIDNEY N SUP SP L is the larger company by market capitalisation. AMANTA shows a lower P/E, a higher ROE and faster revenue growth, while GUJARAT KIDNEY N SUP SP L shows lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AMANTA leads 6; GKSL leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AMANTAGKSL

Valuation lens

What price are you paying?

Market CapContext only
₹749 Cr
₹1,404 Cr
P/E RatioAMANTA has the lower reading
53.58x
85.07x
P/B RatioAMANTA has the lower reading
3.57x
5.34x
EPSAMANTA has the higher reading
₹0.85
₹0.66
Book ValueContext only
₹56.71
₹32.31
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GKSL is the larger company
₹1,404 Cr vs ₹749 Cr
P/E Ratio
AMANTA has a lower P/E
53.58x vs 85.07x
P/B Ratio
AMANTA has a lower P/B
3.57x vs 5.34x
EPS
AMANTA has higher earnings per share
₹0.85 vs ₹0.66
Revenue Growth (TTM YoY)
AMANTA has faster revenue growth
6.8% vs 0%
EPS Growth (TTM YoY)
GKSL has faster EPS growth
0% vs -23.4%
Qtr Sales Growth
GKSL has stronger quarterly sales growth
270.99% vs -76.08%
Qtr Profit Growth
GKSL has stronger quarterly profit growth
161.2% vs -77.74%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAMANTAGKSL
SectorHealthcare
IndustryPharmaceuticals

Price

MetricAMANTAGKSL
Live Price₹150.27₹178
Day Change-4.37%3.29%
Volume3.82 L97,561
52-Week High₹164₹183.05
52-Week Low₹92₹98.36
Distance from 52W High-8.37%-2.76%

Valuation

MetricAMANTAGKSL
Market Cap₹749 Cr₹1,404 Cr
P/E Ratio53.58x85.07x
P/B Ratio3.57x5.34x
EPS₹0.85₹0.66
Book Value₹56.71₹32.31
Dividend Yield0%0%

Growth

MetricAMANTAGKSL
Revenue Growth (TTM YoY)6.8%0%
EPS Growth (TTM YoY)-23.4%0%
Qtr Sales Growth-76.08%270.99%
Qtr Profit Growth-77.74%161.2%

Profitability & Leverage

MetricAMANTAGKSL
ROE6.75%6.6%
ROCE7.89%7.12%
Net Margin5.17%20.5%
Operating Margin14.55%28.18%
Debt to Equity1.06x0.06x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAMANTAGKSL
Promoter Holding26.87% 0.06 pp71.45%
FII Holding0.43% 0.42 pp4.88%
DII Holding12.92% 0.04 pp0.56%
Public Holding22.85% 0.29 pp23.1%

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMANTA and GUJARAT KIDNEY N SUP SP L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.